- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | biote Corp. - 8-K, Current Report | 1 | SEC Filings | ||
| Di | Biote Reports First Quarter 2024 Financial Results | 9 | Business Wire | IRVING, Texas--(BUSINESS WIRE)--Biote (NASDAQ: BTMD), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness,... ► Artikel lesen | |
| 29.04. | biote Corp. - 8-K, Current Report | 1 | SEC Filings | ||
| 04.04. | biote Corp. - S-8, Securities to be offered to employees in employee benefit plans | 1 | SEC Filings | ||
| 15.03. | biote Corp. - 10-K, Annual Report | 1 | SEC Filings | ||
| 13.03. | Jefferies raises Biote stock target to $8.24, maintains buy rating | 1 | Investing.com | ||
| 12.03. | biote Corp. - 8-K, Current Report | 1 | SEC Filings | ||
| 12.03. | BIOTE GAAP EPS of $0.18 beats by $0.11, revenue of $45.7M in-line | 1 | Seeking Alpha | ||
| 12.03. | Biote: Q4 Earnings Insights | 1 | Benzinga.com | ||
| 12.03. | Biote Reports Fourth Quarter and Full Year 2023 Financial Results | 60 | Business Wire | IRVING, Texas--(BUSINESS WIRE)--Biote (NASDAQ: BTMD), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness,... ► Artikel lesen | |
| 11.03. | Preview: Biote's Earnings | 1 | Benzinga.com | ||
| 21.02. | DeSPAC'ed Biote Settles Founder's Lawsuit by Repurchasing all His Shares | 1 | The SPAC Conference | ||
| 20.02. | biote Corp. - 8-K, Current Report | 1 | SEC Filings | ||
| 20.02. | Biote shares rise on bullish B.Riley initiation | 1 | Investing.com | ||
| 01.02. | Jefferies sets $6.55 target on Biote with new buy rating | 1 | Investing.com | ||
| 25.01. | biote Corp. - 8-K, Current Report | 1 | SEC Filings | ||
| 25.01. | Biote announces $20M share repurchase authorization | 1 | Seeking Alpha | ||
| 17.01. | Biote expects 2023 revenue to be below provided outlook | 1 | Seeking Alpha | ||
| 17.01. | Biote to Purchase Asteria Health | 140 | Business Wire | IRVING, Texas--(BUSINESS WIRE)--biote Corp. (NASDAQ: BTMD) ("Biote" or the "Company"), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization... ► Artikel lesen | |
| 17.01. | Biote Provides Preliminary 2023 Results and Initial 2024 Guidance | 145 | Business Wire | IRVING, Texas--(BUSINESS WIRE)--biote Corp. (NASDAQ: BTMD) ("Biote" or the "Company"), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization... ► Artikel lesen |
Seite:
1 2 Weiter >>
26 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ORPEA | 13,620 | -2,55 % | ORPEA S.A.: Filing of the 2023 Universal Registration Document | Regulatory News:
ORPEA S.A. (the "Company") (Paris:ORP) filed, today, its 2023 Universal Registration Document (document d'enregistrement universel) with the French Autorité des Marchés Financiers... ► Artikel lesen | |
| NANO-X IMAGING | 9,500 | -2,06 % | NANO-X Slides as Arm Recognized | ||
| BUTTERFLY NETWORK | 0,985 | -2,92 % | Butterfly Network Reports First Quarter 2024 Financial Results | BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)--Butterfly Network, Inc. (NYSE: BFLY) ("Butterfly" or the "Company"), a digital health company transforming care with handheld, whole-body ultrasound... ► Artikel lesen | |
| GOODRX | 7,620 | +1,46 % | GoodRx Holdings Q1 2024 Earnings Preview | ||
| JOINT CORP | 15,810 | -1,92 % | The Joint Corp. to Participate in Upcoming Investor Conferences | ||
| CARMAT | 3,960 | +11,24 % | CARMAT Continues to Build on Its Momentum in the EFICAS Study and Reiterates Confidence in Its 2024 Outlook | EFICAS study reaches the milestone of 20 implants
Interim study results above expectations
Confirmation of short-term financial support from several key shareholders
Regulatory... ► Artikel lesen | |
| HYPERFINE | 0,800 | 0,00 % | Hyperfine, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results | GUILFORD, Conn., March 21, 2024 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable... ► Artikel lesen | |
| PROGYNY | 32,360 | -2,15 % | Progyny, Inc. Announces Details for Its First Quarter 2024 Results Report | ||
| BIOMERICA | 0,594 | +5,15 % | Biomerica, Inc.: Biomerica Reports Third Quarter 2024 Financial Results | Fiscal Discipline Leads to Improvement as Loss per Share Narrows to $0.27 from $0.40 Amidst Sales Force Expansion for the Nine Months in Fiscal 2024 InFoods IBS Positive Clinical Data to be Presented... ► Artikel lesen | |
| MIMEDX | 7,215 | -1,16 % | MiMedx Group, Inc. (MDXG) Q1 2024 Earnings Call Transcript | ||
| TALKSPACE | 2,610 | -2,97 % | Earnings call: Talkspace reports profitability in Q1 with revenue growth | ||
| ATRICURE | 20,910 | -4,43 % | AtriCure Reports First Quarter 2024 Financial Results | MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and... ► Artikel lesen | |
| ATRION | 386,00 | -3,98 % | Dividendenbekanntmachungen (14.03.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABRDN PLC GB00BF8Q6K64 0,073 GBP 0,0853 EUR ABRDN PLC ADR US00108N1000 0,3203 USD 0,2925 EUR ACCO BRANDS CORPORATION US00081T1088 0... ► Artikel lesen | |
| AMWELL | 0,532 | -4,78 % | Amwell bullish on strong growth from defense contract in 2024 despite declining revenue in Q1 | ||
| CASTLE BIOSCIENCES | 23,820 | +0,11 % | Castle Biosciences Reports First Quarter 2024 Results | FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced its financial results... ► Artikel lesen |
BIOTE CORP gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von +0,145 (+2,50 %) liegt der Kurs bei 5,935 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
